A South Korean pharmaceutical and consumer product company approached Freyr to perform literature monitoring and compile the reports as required by the US FDA. As the client was facing ambiguity on process flow to be followed and the Regulatory requirements of the FDA, it was challenging for them to find adequate Regulatory road maps as required by the US FDA.

Despite these obstacles, how did Freyr performed literature monitoring and submitted the reports? Decode with this proven case.